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The structure of phosphorylated P38γ is monomeric and reveals a
conserved activation-loop conformation
Steve Bellon*, Matthew J Fitzgibbon, Ted Fox, Hsun-Mei Hsiao 
and Keith P Wilson* 
Background: Mitogen-activated protein (MAP) kinases mediate the cellular
response to stimuli such as pro-inflammatory cytokines and environmental
stress. P38γ is a new member of the MAP kinase family, and is expressed at its
highest levels in skeletal muscle. P38γ is 63% identical in sequence to P38α.
The structure of P38α MAP kinase has been determined in the apo,
unphosphorylated, inactive form. The structures of apo unphosphorylated
ERK2, a related MAP kinase, and apo phosphorylated ERK2 have also been
determined.
Results: We have determined the structure of doubly phosphorylated P38γ in
complex with an ATP analog by X-ray crystallography. This is the first report of a
structure of an activated kinase in the P38 subfamily, and the first bound to a
nucleotide. P38γ residue phosphoryl-Thr183 forms hydrogen bonds with five
basic amino acids, and these interactions induce an interdomain rotation. The
conformation of the activation loop of P38γ is almost identical to that observed
in the structure of activated ERK2. However, unlike ERK2, the crystal structure
and solution studies indicate that activated P38γ exists as a monomer.
Conclusions: Interactions mediated by phosphoryl-Thr183 induce structural
changes that direct the domains and active-site residues of P38γ into a
conformation consistent with catalytic activity. The conformation of the
phosphorylation loop is likely to be similar in all activated MAP kinases, but not
all activated MAP kinases form dimers.
Introduction
Mammalian mitogen-activated protein (MAP) kinases are
proline-directed serine/threonine kinases that facilitate
signal translocation in cells [1–3]. MAP kinases have
similar sequences and three-dimensional structures [4,5],
and include the extracellular signal regulated kinases
(ERKs), the c-Jun NH2-terminal kinases (JNKs) and the
P38 kinases. P38γ is a new member of the MAP kinase
family [6], and is 63% identical to P38α MAP kinase. P38γ
is expressed at its highest levels in skeletal muscle [6,7],
whereas other P38 family members are expressed in many
tissues [8]. Thus P38γ may have a unique function. The
JNK and P38 kinases are activated in response to the pro-
inflammatory cytokines tumor necrosis factor-α (TNF-α)
and interleukin-1 (IL-1), and by cellular stress such as
ultraviolet light, heat shock, and inhibition of protein syn-
thesis [8–10]. In contrast, ERKs are activated by mitogens
and growth factors.
MAP kinases must be doubly phosphorylated to achieve
full enzymatic activity [8,11]. Phosphorylation occurs on the
hydroxyl groups of threonine and tyrosine residues within a
Thr-X-Tyr motif, where X is proline for ERK, glutamatic
acid for JNK, and glycine for kinases in the P38 family [1,2].
The residues phosphorylated in the active form of P38γ are
Thr183 and Tyr185. Because the Thr-X-Tyr motif is
located in a surface loop near the active site, the loop is
referred to as the phosphorylation loop or activation loop.
P38α MAP kinase is a target for a class of pyridinylimida-
zole compounds that block the production of IL-1 and
TNF-α from monocytes stimulated by endotoxin [12].
These inhibitors bind in the ATP site of P38α [13–15].
Studies with these compounds have shown that P38 MAP
kinase plays a role in the TNF-induced transcription of
IL-6 and granulocyte macrophage colony stimulating
factor (GM-CSF) [16], and the proliferation of T cells after
exposure to IL-2 and IL-7 [17]. The pyridinylimidazole
compounds do not inhibit the activity of ERK2 [18], JNK3
[19], or P38γ [7,15], despite high sequence conservation in
the ATP-binding site between these kinases.
To understand further the structural and biochemical con-
sequences of MAP kinase activation, we determined the
structure of phosphorylated P38γ. This is the first report of
a structure of an activated kinase in the P38 subfamily, and
the first bound to a nucleotide. The activated P38γ struc-
ture is compared with the structures of unphosphorylated
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apo P38α, ERK2, and JNK3, and phosphorylated ERK2
and cAPK. P38α is the most closely related MAP kinase of
known structure, and is thus a model for the unphosphory-
lated form of P38γ. ERK2 is the only other activated MAP
kinase of known structure, and was solved without
nucleotide bound [20,21]. The structure of JNK3 was
solved in complex with AMP-PNP, a nonhydrolyzable
ATP-like inhibitor [19]. The structure of cAPK was solved
bound to ATP and a peptide inhibitor [22–24], and,
although not a member of the MAP kinase family, the
cAPK structure is believed to represent a bioactive confor-
mation of kinases. 
Comparisons between these kinase structures reveal that
interactions mediated by P38γ residue phosphoryl-Thr183
(pThr183) induce a rigid-body rotation, and reorient the
domains and catalytic residues of P38γ into a conformation
consistent with activity. The conformation of the activa-
tion loop is almost identical in phosphorylated P38γ and
ERK2, and we conclude that the conformation of the
phosphorylation loop is likely to be similar in all activated
MAP kinases. Unlike ERK2, however, the structure of
activated P38γ does not reveal a dimer interface. This
observation is supported by solution studies that indicate
that activated P38γ exists as a monomer, suggesting that
not all activated MAP kinases form dimers.
Results and discussion
Structure determination of activated P38γ in complex with
MgAMP-PNP
Crystals of phosphorylated P38γ in complex with AMP-
PNP and Mg2+ were used to determine the structure. The
crystals diffract X-rays to higher than 2.4 Å resolution
along the crystallographic c* direction, and to about 3.0 Å
in the perpendicular direction. The structure was refined
against data to 2.4 Å. No useable crystals could be
obtained in the absence of an ATP-like ligand.
The P38γ structure was solved with a combination of low-
resolution multiple isomorphous replacement (MIR) and
molecular replacement using a model of the unphosphory-
lated form of P38α [25]. The current structure includes
two P38γ molecules per asymmetric unit, each with 329
amino acids, a bound AMP-PNP, and two Mg2+ ions. A
total of 186 water molecules were modeled in the asym-
metric unit. The current Rfree and Rwork are 28.3% and
23.2%, respectively. The refined model has deviations
from ideal bond lengths and angles of 0.01 Å and 1.6°.
The two P38γ molecules in the asymmetric unit superim-
pose with an overall root mean square deviation (rmsd) of
0.013 Å using all Cα atoms, and thus represent two inde-
pendent but highly similar structures of activated P38γ.
Overview of the structure of activated P38γ
Electron density for the mainchain atoms of P38γ is visible
from residue 8 to 353, with breaks at residues 34–39,
316–321 and 330–334 (Figure 1). The glycine-rich loop,
which contains the consensus Gly-X-Gly-X-X-Gly
sequence (residues 34–39 in P38γ) is mobile, and residues
34–39 could not be modeled. The homologous region of
P38α is also flexible, and has average B values equal to
61 Å2. In contrast, the AMP-PNP ligand is well ordered, as
are all nearby secondary structural elements. Strong elec-
tron density for the residues at the N- and C-terminal
ends of the glycine-rich loop is also observed. The C-ter-
minal 40 residues of both P38γ molecules in the asymmet-
ric unit are not as well ordered as the rest of the structure.
Helix αL16 can be modeled, but it contains several disor-
dered sidechains. The region just before helix αL16 is
poorly ordered and does not form the 3/10 helix L16
observed in the structure of phosphorylated ERK2. Helix
αL16 and 3/10 helix L16 are involved in dimer formation
in the structure of phosphorylated ERK2 [21].
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Figure 1
Overview of the phosphorylated P38γ structure. The large and small
domains are pulled together by interactions mediated by phosphoryl-
Thr183 (pThr183). Ribbon diagram of the activated P38γ structure
with the N-terminal small domain colored light orange and the
C-terminal large domain colored blue. The interface between the two
domains (residue 113) can be thought of as a hinge point through
which domain movement occurs. Four arginine residues and one lysine
residue are explicitly shown coordinated to the phosphate of pThr183.
Arg70, Arg73 and Lys69 anchor the small domain to pThr183, and
Arg152 and Arg176 anchor the large domain to pThr183; pThr183
pulls the domains together. All figures were made with the program
RIBBONS [40].
Activated P38γ contains a small N-terminal domain com-
prised mainly of β strands, and a large C-terminal domain
that consists mostly of α helices (Figure 1). This fold is
common among kinases [4,5]. A deep cleft at the interface
between the domains forms the binding site for ATP and
Mg2+. The two domains are connected by a hinge, located
at a point adjacent to the adenine base and near residue
113 (Figure 1).
The domains of activated P38γ are closed relative to P38α
The sequence, fold, and topology of P38γ are similar to
those of P38α (Figures 1 and 2). Independent superimpo-
sitions of the domains of P38γ onto the P38α structure
yield rms deviations of 1.2 Å for the N-terminal domain
(P38γ Cα carbons from residues 10 to 16, 19 to 33, and 40
to 113), and 0.62 Å for the C-terminal domain (P38γ Cα
carbons from residues 125 to 160, 206 to 238 and 282 to
297). Greater differences between P38γ and P38α are
observed when the whole proteins are compared. Super-
imposition of the C-terminal domain of P38γ onto the cor-
responding lobe of P38α revealed a rotation of the
N-terminal domain of P38γ by 20° relative to the orienta-
tion seen in P38α (Figure 2). Other differences between
the structure of phosphorylated P38γ and P38α occur in
the conformation of α1L14, α2L14, α1L12, the phos-
phorylation loop, and αL16.
Interdomain rotation, or domain closure, is common in
MAP kinase structures, and is observed to different
extents. The structures of unphosphorylated and phos-
phorylated ERK2 show a 5° difference in domain closure.
The structure of unphosphorylated JNK3 reveals that a
10° domain rotation would be needed to superimpose
both domains with the structure of phosphorylated P38γ or
phosphorylated ERK2. P38α MAP kinase is more open in
its unphosphorylated state than ERK2 or JNK3. Despite a
large difference in the conformations of the unphosphory-
lated proteins, the domains of the activated forms of P38γ
and ERK2 can be superimposed with a rotation of only 3°.
Comparison to solved kinase structures indicates that the
relative positions of the domains in activated P38γ is most
similar to activated ERK2 MAP kinase.
The structures of phosphorylated P38γ and phosphory-
lated ERK2 are quite similar, with a few significant differ-
ences. One conformational difference is a movement of
the α1L14, α2L14 helical region. With the large domains
superimposed, the difference in α1L14, α2L14 orienta-
tion between the two structures is about 6 Å, when mea-
sured at the most extreme portion of the helices. Another
difference between the two structures is that the P38γ
activation loop is six residues shorter than the activation
loop in ERK2. Excluding these two regions allows one to
superimpose P38γ Cα carbons 19–33, 40–58, 61–94,
97–113, 117–177, 182–243, and 269–315 with the corre-
sponding ERK2-P2 atoms to yield an rmsd of 1.1 Å. This
reflects the high similarity between the two structures. A
comparison of the activation loops, using P38γ Cα carbons
173–177 and 182–188 yields an rmsd of 0.3 Å.
The interdomain orientation observed for activated P38γ
is not likely to be due to crystal-packing forces. Two mol-
ecules of P38γ are observed in the asymmetric unit of the
crystal, and each is stabilized by different crystal contacts.
As the conformation of each independent molecule is
almost identical, the structures observed probably repre-
sent the most stable conformation of phosphorylated P38γ.
Phosphorylated Thr183 interactions lead to domain closure
The structure of the phosphorylation loop differs between
phosphorylated P38γ and unphosphorylated P38α
(Figure 2). The phosphorylation loop contains the Thr-Gly-
Tyr sequence present in all P38 MAP kinases. Phosphoryla-
tion of Thr183 and Tyr185 results in a movement of the
activation loop, and produces changes in the P38γ structure.
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Figure 2
Superimposition of unphosphorylated P38α and phosphorylated P38γ.
P38α is shown in light blue and dark blue (activation loop), and P38γ
is shown in light orange and dark orange (activation loop). The Cα
atoms from residues 125 to 160, 206 to 238 and 282 to 297 were
used to superimpose the two proteins with an rmsd of 0.62 Å. Also
shown is the AMP-PNP and two Mg2+ ions from the P38γ structure. All
atoms of the phosphorylated Thr183 and Tyr185 from the P38γ
structure are shown. Major changes upon phosphorylation are a
significant domain closure and a rearrangement of the activation loop.
pThr183 sits at the interface between the two domains.
The Thr183 phosphate group interacts with Arg70,
Arg73 and Lys69 from the N-terminal domain, and
Arg152 and Arg176 from the C-terminal domain
(Figures 1 and 3). The two domains are connected by a
hinge, located at a point adjacent to the adenine base and
near residue 113. The hinge point and residue pThr183
are located at opposite ends of the interface between the
two domains. The network of interactions between
pThr183 and these basic residues pulls the domains
together. As a result, the relative orientations of the
amino acids, including the catalytic residues, located
between the hinge and pThr183 are changed. A similar
set of interactions between the pThr183 and nearby
basic residues was observed in the structure of phospho-
rylated ERK2 [21].
Phosphorylated P38γ is in a conformation compatible with
activity
The active site of phosphorylated P38γ is shown in detail
in Figure 4, and it is compared with the active sites of
P38α and cAPK in Figures 5a and b. The interactions
between the nonhydrolyzable nucleotide analog AMP-
PNP and P38γ (Figure 4) are very similar to those made
between the bound nucleotide and cAPK [22–24]. The
N1 and N6 nitrogen atoms of AMP-PNP form hydrogen
bonds to the backbone amide nitrogen atom of Met112
and the backbone carbonyl oxygen atom of Pro110,
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Figure 3
Detailed stereoview of the activation loop. All-
atom stereoview of the P38γ activation loop
(residues 174–189). Residues that
coordinate pThr183 and pTyr185 are also
shown. Hydrogen bonds are indicated by
dashed gray lines. The phosphate atoms are
shown in purple.
Figure 4
Stereoview of AMP-PNP. All major
interactions with protein sidechains are
indicated by dashed gray lines. The bound
Mg2+ ions are indicated by black spheres. The
phosphate atoms are shown in purple.
Met109 can be seen behind the adenine
base, blocking the hydrophobic pocket. Water
molecules have been removed for clarity.
respectively. Interactions between the glycine-rich loop
and the nucleotide are not observed in the P38γ structure.
The relative positions of catalytic residues Lys53, Glu74
and Asp153 provide information about the state of activa-
tion of the kinase [26,27]. Comparison of P38γ with cAPK
after superimposing the nucleotides from the two struc-
tures (Figure 5b) reveals an almost identical conformation
of active-site residues in the two structures. The cAPK
structure also contains a bound peptide inhibitor, and the
complex is believed to represent a bioactive conformation
of cAPK [22–24]. The nucleotides in both structures adopt
almost identical conformations, and the relative positions
of the catalytic residues Lys56, Glu74 and Asp153 are con-
served. There are also two bound metal ions in each
complex. After superimposition, metal I in cAPK is sepa-
rated from the corresponding metal in P38α by 0.5 Å, and
metal II from P38γ is 1.4 Å removed from metal II in
cAPK. Because the conformation and relative orientation
of the catalytic residues and cofactors in the active sites of
the two kinases are almost identical, the structure of phos-
phorylated P38γ reported here is likely to represent an
active conformation.
Activation of P38γ results from a rigid-body rotation of the
two domains and unblocking of the substrate-binding site
The active-site residues of P38α are significantly dis-
placed relative to their orientation in P38γ, presumably
reflecting an inactive state of unphosphorylated P38α
(Figure 5a). Two types of structural differences are
observed between P38α and activated P38γ. A rigid-body
motion occurs between the two domains, and secondary
structure elements and residues move as a result of phos-
phorylation and AMP-PNP binding. Is the domain move-
ment enough to properly position the catalytic residues in
an active conformation [28–31], or does activation result
from a combination of a rigid-body domain movement and
other changes?
To address this question, the structure of unphosphory-
lated P38α was altered to resemble phosphorylated P38γ.
Only a rigid-body movement, centered on the hinge
residue 113, was used to change the relative orientation of
the two domains in P38α. The resulting model maintains
the detailed secondary structure features present in non-
phosphorylated P38α, but has the same domain closure as
P38γ. The positions of catalytic residues in the active site
of this modified P38α model correspond well with those
observed in the structure of activated P38γ. The rigid-
body movement shifts P38α residue Lys53 2.9 Å closer to
its counterpart in P38γ (from 4.4 Å to 1.5 Å separation).
Glu71 (P38α) moves 2.8 Å nearer to its equivalent residue
in P38γ (from 3.2 Å to 0.4 Å separation). Thus, the struc-
tures of P38α and P38γ suggest that a simple domain rota-
tion accounts for most of the rearrangement of catalytic
residues necessary for activation of P38γ [28–31].
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Figure 5
Comparison of the active site of activated P38γ with P38α and cAPK.
P38γ is shown in orange, P38α in blue, and cAPK in red. In all three
structures a salt bridge is observed between Lys56 and Glu74 (P38γ
numbering). (a) Comparison of the active sites of P38γ with P38α by
superimposition of their C-terminal large domains. Catalytic residues are
misaligned. The distance between Asp153 and Lys53 is 12.6 Å in the
P38α structure compared with 8.5 Å in the phosphorylated P38γ
structure. (b) Comparison of the active sites of P38γ with cAPK (Protein
Data Bank code 1ATP [22]) by superimposition of all atoms of their
bound AMP-PNP molecules. All catalytic residues align to within a fraction
of an angstrom. The distance between Asp153 and Lys53 is 8.5 Å in the
activated P38γ structure. This distance is very close to the distance of
7.8 Å observed in activated cAPK, suggesting that the structure reported
here is of the activated kinase. Asp171 is excluded from these figures for
clarity because it is obscured by AMP-PNP and Mg2+ ions.
Other movements contribute to activation of P38γ . Phos-
phorylation of Tyr185 leads to a rearrangement of sur-
rounding secondary structure elements that could effect
substrate binding. Arg192 blocks the P+1 site in the struc-
tures of unphosphorylated ERK2 [20] and unphosphory-
lated JNK3 [19]. In the structure of phosphorylated
ERK2, Arg192 coordinates the Tyr185 phosphate and
opens a channel to permit substrate binding [21]. In a
similar fashion, Arg192 interacts with the pTyr185 phos-
phate group in the P38γ structure, and is shifted more than
5 Å relative to its position in the apo P38α structure. This
movement helps unblock the peptide-binding channel. It
has been suggested (based on the structure of phosphory-
lated ERK2) that the basis for proline-specific substrate
recognition at the P+1 substrate-binding site in ERK2 is
due in part to the conformation of pTyr185 [21]. In our
P38γ structure, pTyr185 interacts directly with Arg189 and
Arg192 (Figure 3). The same interactions were observed
in the structure of phosphorylated ERK2. Based on
models of a Thr-Pro-Ala peptide bound to ERK2,
pTyr185 was shown to be important in proline recogni-
tion. Comparison of the P38γ pTyr185 conformation, as
well as the backbone conformation with the corresponding
residue of phosphorylated ERK2, shows that the two
residues are in virtually the same conformation. It is possi-
ble that P38γ and ERK2 MAP kinases use the same mech-
anism for proline specificity in the P+1 substrate site.
The structure of activated P38γ does not suggest dimer
formation
The structure of activated ERK2 revealed a dimer inter-
face that was not observed in the nonphosphorylated form
[20,21,32]. Evidence was presented to show that dimer
formation might play a role in the translocation of acti-
vated ERK2 kinase to the nucleus [21,32]. The dimer
interface in phosphorylated ERK2 buries a total of
1470 Å2 of surface area, and is formed in part by an ion pair
between His176 from one molecule and Glu343 from the
other molecule. In addition, Leu333, Leu336, and Leu344
further stabilize the dimer interface. To test the transloca-
tion hypothesis, a pentamutant of ERK2 was made with
His176 mutated to glutamate and with Leu333, Leu336,
Leu341, and Leu344 mutated to alanine (H176E L4A
ERK2). This mutant did not form dimers in gel-filtration
and equilibrium-sedimentation experiments, and exhib-
ited reduced accumulation of ERK2 in the nucleus [32].
Either the single mutation H176E, or a deletion of P174
through D177 (ERK2∆4) was also sufficient to prevent
dimerization. Surprisingly, the tetramutant L333A,
L336A, L341A, L344A was observed to form dimers.
Thus, the ion pair His176–Glu343 seems to be essential
for dimer formation in phosphorylated ERK2.
As P38γ is the second activated MAP kinase structure to
be determined, the residues of P38γ that correspond to
His176, Glu343, Leu333, Leu336, and Leu344 of ERK2
were examined to determine their involvement in
protein–protein interactions in the P38γ crystal. His176
lies at the tip of the activation loop in ERK2-P2, in a
region that is inserted into the ERK2 activation loop rela-
tive to the P38γ activation loop. Examination of the activa-
tion loops of both P38γ molecules reveals that they are not
involved in any dimeric interaction.
The three ERK2 leucine residues (Leu333, Leu336, and
Leu344) correspond to Asp332, Arg335, and Val343 in
P38γ. In general, the corresponding regions of P38γ are
more disordered than the rest of the protein. Asp332 lies
in a disordered region of P38γ. Although their sidechain
density is disordered, Arg335 and Val343 lie in well-
ordered mainchain density, and Val343 sits within helix
αL16, which is involved in phosphorylated ERK2 dimer-
ization. Helix αL16 has a few disordered sidechains, but
the mainchain is clearly visible in the electron density.
Most importantly, the location of this helix in P38γ is vir-
tually identical to its position in ERK2-P2. Examination of
the structures of both independent P38γ molecules from
the asymmetric unit shows that αL16 is not involved in a
dimeric interaction.
We examined the entire surface of each P38γ molecule in
the asymmetric unit in search of any dimer interface. Our
crystal of P38γ belongs to space group P212121, which con-
tains only twofold screw axes, but no crystallographic
twofold axes. The only twofold axis in the crystal is the
noncrystallographic axis that relates the two molecules
within the asymmetric unit. This dimeric interaction
involves Pro282, Asn286, Lys290, Leu283, Pro309, and
Glu312. This noncrystallographic dimer interface buries
680 Å2 of surface area, less than half of the 1470 Å2 buried
in the phosphorylated ERK2 dimer interface. This sug-
gests that the interaction is a crystal-lattice contact with no
biological significance. Thus the P38γ structure does not
indicate that activated P38γ forms dimers as part of its
mechanism of action.
To characterize further the oligomeric state of activated
P38γ in solution, size-exclusion chromatography was per-
formed to determine the apparent molecular weights of
unphosphorylated and phosphorylated P38γ. To facilitate
comparison with the phosphorylated ERK2 results [32],
the same column resin, buffer, and loading conditions
were used. The chromatographic profiles of unphosphory-
lated and phosphorylated P38γ showed that both proteins
eluted with a similar retention time, corresponding to a
molecular weight of 44.5 kDa as determined from the
protein calibration curve. The absence of dimer formation
of phosphorylated P38γ in solution is consistent with the
absence of dimer formation in the crystal structure of P38γ.
The observation that phosphorylated P38γ does not form
dimers in solution or in our crystals may be explained by
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the mutational work with phosphorylated ERK2 [32]. In
phosphorylated ERK2, the ion pair between His176 and
Glu343 is essential for dimer formation, and shortening
the activation loop of ERK2 by four residues (174–177)
abolished dimerization. The P38γ activation loop is six
residues shorter than that of ERK2 and lacks a corre-
sponding histidine residue. Thus, the absence of dimer
formation for P38γ is consistent with the observations for
the mutants of phosphorylated ERK2.
Met109 blocks binding of pyridinylimidazole compounds to
P38γ
Pyridinylimidazole compounds are inactive against P38γ
[7,15]. The structure provides an explanation for this
observation. Pyridinylimidazole compounds inhibit P38α
in part because a fluoro-phenyl group of the inhibitor fits
into a hydrophobic pocket located deep within the
nucleotide-binding site [13–15]. Residue 109 forms one
part of the pocket. Substitution at residue 109 modulates
the activity of certain pyridinylimidazole compounds by
almost three orders of magnitude [13–15]. Small residues
such as threonine and alanine at position 109 allow the
fluoro-phenyl ring of this inhibitor class to fill the
hydrophobic pocket. Larger residues such as methionine
block this pocket, so that the pyridinylimidazole com-
pounds cannot bind. The structure of phosphorylated
P38γ shows that Met109 fills the hydrophobic pocket, and
provides a structural explanation for the inactivity of
pyridinylimidazole inhibitors against P38γ.
The conformation of the phosphorylated activation loop is
conserved
The number of residues in the activation loops of differ-
ent kinases varies, ranging from eight amino acids in
calmodulin-dependent death-associated protein kinase
(DAP-kinase) [33] to 37 in LIM-motif-containing protein
kinase-2 (LIMK2) [34]. The P38γ activation loop consists
of residues Gly173–Thr188. The phosphorylation loop of
ERK2 is six residues longer in sequence and spans amino
acids Gly167–Thr188. The loop region of cAPK is the
same length as the one in P38γ, and spans amino acids
Gly186–Thr201. Figure 6 highlights the loop regions from
P38γ, ERK2-P2, and cAPK. Except for a longer loop size
for ERK2, the structures of the loop regions of activated
P38γ and activated ERK2 are nearly identical. The dis-
tance between the phosphate moieties from Thr183 in
P38γ and ERK2 is only 0.4 Å, and separation between the
Tyr185 phosphate from P38γ and ERK2 is 1.6 Å. The
phosphorylation loop of cAPK does not superimpose as
well with the two MAP kinase phosphorylation loops,
although the threonine phosphate is only 2.0 Å away from
the P38γ Thr183 phosphate.
The phosphorylation-loop regions from P38γ, ERK2 and
cAPK have different lengths, but in their phosphorylated
states adopt almost identical conformations. It seems
likely that the phosphorylated activation loop structures of
other MAP kinases will be similar to those for P38γ and
ERK2. Conservation of the phosphorylation-loop structure
may reflect the importance of properly orienting the
kinase domains for enzymatic activity.
Biological implications
JNK and P38 kinases are activated in response to the
pro-inflammatory cytokines tumor necrosis factor-α and
interleukin-1, and by cellular stress such as ultraviolet
light, heat shock, and inhibition of protein synthesis
[8–10]. P38γ is a new member of the MAP kinase family
[6], is 63% identical to P38α MAP kinase, and is most
prevalent in skeletal tissue.
We report here the structure of phosphorylated P38γ in
complex with AMP-PNP, an ATP analog, and Mg2+.
Phosphorylation of Thr183 and Tyr185 produces
changes in structure throughout the enzyme. The phos-
phorylated p38γ residue pThr183 pulls the two domains
of P38γ together by interacting with arginine and lysine
residues from both lobes. The domain movement induces
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Figure 6
Comparison of activated phosphorylation loops from P38γ (dark
orange), ERK2 (dark blue), and cAPK (red). Superimposition of these
three structures was performed with the Cα atoms of residues
125–160, 206–238 and 282–297 of P38γ. In order to ensure an
unbiased comparison of the lip regions, these residues were omitted
from the calculation. All three lip regions have different lengths, but
have surprisingly similar conformations. Comparison of P38γ and
ERK2 superimposes the two phosphorylated amino acids almost
exactly, despite a six amino acid difference in length. The
phosphorylated Thr197 of cAPK also superimposes well with the two
MAP kinase structures. This comparison suggests that the
phosphorylated lip structures observed in P38γ and ERK2 may be
representative of all MAP kinases.
a shift in the positions of the catalytic residues [28–31].
The arrangement of the catalytic residues in P38γ is
almost identical to that observed in the structure of
cAPK, which is believed to be in an active conformation.
Thus, the structure of P38γ reported here is likely to rep-
resent an active conformation. The structure of the acti-
vation loop for P38γ is almost identical to the structure of
the activation loop seen in phosphorylated ERK2.
Unlike ERK2, however, the structure of activated P38γ
does not reveal a dimer interface. We conclude that the
conformation of the phosphorylation loop is likely to be
similar in all activated MAP kinases, but that not all
activated MAP kinases form dimers.
Materials and methods
P38γ with a six-histidine tag was overexpressed in Escherichia coli, and
then purified by using metal affinity resin followed by MonoQ resin. The
purified material was phosphorylated with constitutively active MKK6,
and purified again with MonoQ resin (TF and M Fleming, unpublished
results). Size-exclusion chromatography was performed to determine
the apparent molecular weights of unphosphorylated and phosphory-
lated P38γ as follows. A Superdex 75 HR 10/30 column (Pharmacia,
Uppsala) was equilibrated in 12.5 mM HEPES pH 7.3, containing
6.25% (v/v) glycerol and 100 mM KCl. Bovine serum albumin (67 kDa),
ovalbumin (43 kDa), chymotrypsinogen (25 kDa) and ribonuclease A
(13.7 kDa) were used to calibrate the column prior to P38γ analyses. A
flow rate of 0.25 ml/min was used for chromatographic runs and
samples were loaded in a volume of 100–200 µl at 0.7–4 mg/ml.
Crystals of phosphorylated P38γ complexed with AMP-PNP were grown
by vapor diffusion. Clusters of rods appeared after 3–7 days when
protein (0.5 mM P38γ with 5 mM AMP-PNP and 0.02% C12E9) was
mixed with an equal volume of reservoir (100 mM NaOAc, 100 mM Tris
pH 8.5, 27% PEG 4000, 10 mM MgCl2, and 5 mM DTT) and allowed to
stand at room temperature. Single crystals with 100 µm maximum thick-
ness were separated from their parent cluster, cryoprotected by adding
ethylene glycol to a final concentration of 15% over 15 min in three equal
steps, and flash cooled to –170°C in a stream of gaseous nitrogen.
The diffraction pattern displayed symmetry consistent with space group
P212121, with unit-cell dimensions a = 63.50 Å, b = 66.82 Å, and
c = 206.02 Å. Diffraction extended to 4.0 Å in the a*, b* direction and
3.0 Å in the c* direction. Data collection at NSLS X25 allowed a signifi-
cant improvement in the observed diffraction limit: data were collected
to 3.0 Å in the a*, b* direction and at least 2.4 Å in the c* direction. Data
were integrated to 2.4 Å [35,36]. The overall Rmerge for the data was
6.7%, with I/sig(I) = 2.0 at 2.4 Å resolution. The X-ray data comprised
31,732 unique reflections derived from 118,429 intensity measure-
ments. The data were 90% complete overall and 76.5% complete in the
2.49–2.40 Å resolution shell. Data incompleteness, particularly in the
highest resolution shell, reflects the anisotropic nature of the diffraction.
The volume of the asymmetric unit indicated the presence of two P38γ
molecules. The self-rotation function calculated with POLARRFN [37]
revealed a noncrystallographic peak with intensity half of the origin at
Kappa = 180°, omega = 90°, and Phi = 44°.
Coordinates for the structure of phosphorylated ERK2 were not initially
available from the Protein Data Bank and could not be used for molecu-
lar replacement. Several different models for P38γ were constructed
based on the X-ray coordinates of P38α or unphosphorylated ERK2
[20,25], with either all sidechains truncated to alanine, or with only the
nonconserved sidechains truncated to alanine or glycine. No rotation-
function solutions were obtained using these models with either the
X-PLOR or AMORE molecular replacement packages. The anisotropy
of the data, as well as the presence of two molecules in the asymmetric
unit, could be reasons for the lack of a successful molecular-replace-
ment solution. Variability in the orientation between the large and small
kinase domains may have been an additional complicating factor.
To position correctly an initial P38γ model, experimental phases at low
resolution were obtained from two derivatives. Crystals were soaked
with 0.2 mM ethylmerurychloride (EMP) for five days, and with 2 mM
EuCl3 overnight. Diffraction data were collected on the in-house
R-axisIIc, and integrated to 5.0 Å [35,36]. Difference Patterson maps
were interpreted by using SHELXS-97 [38]. The EMP derivative
yielded four sites and the Europium derivative yielded two sites. These
heavy-atom positions were refined by using ML-PHARE [37], which
yielded an overall figure of merit of 0.53 to 5 Å. The resulting electron-
density maps showed clear solvent and protein regions. Six heavy-atom
sites were identified within a continuous envelope of protein density
and were grouped into two sets of three sites. These two sets were
related to one another by a twofold axis, which was consistent with the
self-rotation function. Each set of three sites was assumed to corre-
spond to a monomer of P38γ, and the twofold operation was used to
improve the experimental electron density by noncrystallographic sym-
metry (NCS) averaging. Solvent-flattening combined with twofold aver-
aging using Dm [37] (final correlation coefficient of averaging of 0.851)
produced an electron-density map at 5.0 Å that allowed placement of
the P38γ model. The N-terminal domain had to be rotated by several
degrees with respect to the C-terminal domain in order to fit both
domains into the experimental density. At this stage the model was
refined against the high-resolution synchrotron data. Rigid-body refine-
ment and torsional-dynamics refinement yielded an initial Rfree of 42%.
The quality of the model was improved by cycles of model building, posi-
tional refinement, and thermal-factor refinement, interspersed with tor-
sional-dynamics runs using data from 50.0 to 2.4 Å. All stages of model
refinement were carried out using the new program CNS [39] with bulk-
solvent correction and anisotropic scaling. NCS restraints were applied
throughout the refinement. The current P38γ model contains two
monomers, each with 329 protein residues, one bound AMP-PNP mol-
ecule, and two Mg2+ ions. A total of 186 water molecules were included
in the entire asymmetric unit. The current Rwork is 23.2% (Rfree = 28.3%)
versus all data with |F| > 2σ(F) between 50–2.4 Å resolution (27,841
reflections). PROCHECK [37] was used to analyze the model stereo-
chemistry. All of the residues were in the most-favored and additional-
allowed regions of the Ramachandran plot. One residue per monomer
(Val187) from the phosphorylation loop was in the disallowed region.
The P38γ model has deviations from ideal bond lengths and angles of
0.010 Å and 1.63° respectively. No electron density was observed for
amino acids 1–7, 34–39, 316–321, 330–334, and 354–end, therefore
these residues were not included in the model. The  histidine tag and 21
residues at the C terminus are also disordered. Subsequent to the struc-
ture refinement, the phosphorylated ERK2 coordinates were released,
and the final refined P38γ structure was compared with that structure.
Accession numbers
The present coordinates have been deposited with PDB accession
number 1cm8.
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